Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clonal Architecture of ASXL1-mutated Myelofibrosis

NCT05710211 is registered in ClinicalTrials.gov with University Hospital, Angers as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05710211 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clonal Architecture of ASXL1-mutated Myelofibrosis
Lead sponsor
University Hospital, Angers
Phase
Not applicable
Overall status
Recruiting
Start date
April 24, 2023
Completion date
April 23, 2031
Enrollment
50 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

myelofibrosis